Addressing Biosecurity Risks in Private Laboratories and Biological Supply Chains

Authors

  • Shravishtha Ajaykumar

DOI:

https://doi.org/10.56042/sd.v9i4.34452

Abstract

In November 2025, a doctor from Hyderabad with access to laboratory materials was investigated for his alleged attempt to manufacture ricin out of his personal residence. Ricin, a biological toxin derived from castor beans, is defined as a category B bioterrorism agent by the US Centers for Disease Control and Prevention (CDC). The investigations found castor materials and laboratory equipment from the premises. The incident highlighted the broader problem of how access to laboratory materials and knowledge can be weaponised when controls are not in place. This case clearly revealed issues of existing biosafety, where biological agents and toxins may impact populations through unintended externalities, such as leaks or mishandling, and biosecurity, where such agents are actively deployed to harm targets by malicious actors.

Downloads

Published

2026-10-08

Issue

Section

For Editor Only

How to Cite

(1)
Shravishtha Ajaykumar. Addressing Biosecurity Risks in Private Laboratories and Biological Supply Chains. SD 2026, 9 (4), 23-26. https://doi.org/10.56042/sd.v9i4.34452.